RIVANNA MEDICAL ANNOUNCES RECEIPT OF CE MARKING, AND ISO 13485 CERTIFICATION
CHARLOTTESVILLE, Virginia, June 7, 2016—After recently launching international expansion in the Middle East, RIVANNA prepares for European Market adoption of Accuro™ with the appointment of a new Vice President of Sales, Europe, the Middle East, and Africa (EMEA).
“As RIVANNA continues to effectuate global, clinical adoption of Accuro, Andrew Hatton, former Vice President of Sales EMEA for Hologic, joins RIVANNA as a key member of the leadership team bringing with him a record of accomplished sales objectives in EMEA,” says RIVANNA Chairman and CEO Will Mauldin. “This appointment, along with our recent receipt of the CE marking and ISO 13485 certification, is essential for our European and international expansion.”
“I am excited to be given the opportunity to introduce the ground breaking product, Accuro, to the EMEA market and to be a key element in RIVANNA’s international growth strategy.” Says Andrew Hatton, new Vice President of Sales EMEA.
ABOUT ACCURO
For anesthesia providers, the affordable, hand-held, and untethered Accuro, by RIVANNA, removes the uncertainty of blind-needle guidance. Unlike conventional ultrasound technologies, Accuro is the world’s first ultrasound-based system specifically designed to help you apply spinal and epidural anesthesia with automated 3D navigation of the lumbar spine identifying epidural location, depth, and trajectory. Accuro’s easy-to-use, innovative technology will improve the efficacy of ultrasound-guided spinal anesthesia helping avoid complications and advance patient outcomes. Certainty can be effortless.
ABOUT RIVANNA MEDICAL
RIVANNA, located in Charlottesville, Virginia, is the innovative medical-device company that imagined, engineered and commercialized Accuro. Addressing the last frontier of image guidance in anesthesia, RIVANNA’s revolutionary application of automated 3D-navigation technology to ultrasound imaging of the spine gives anesthesia providers an intuitive extension of their hands to precisely administer epidural and spinal anesthesia. This proprietary imaging device is FDA 510(k)-cleared for spinal-anesthesia guidance and a variety of additional imaging applications. For information about the easy-to-use Accuro or the medical-device company RIVANNA, please visit rivannamedical.com.
Copyright © by Rivanna Medical, LLC. All rights reserved. RIVANNA, Accuro, BoneEnhance™, and SpineNav3D™ are trademarks of RIVANNA Medical, LLC.
The Accuro ultrasound system is covered by U.S. and foreign patents pending